المؤلفون: Gunst, Jesper D., Pahus, Marie H., Rosás-Umbert, Miriam, Lu, I. Na, Benfield, Thomas, Nielsen, Henrik, Johansen, Isik S., Mohey, Rajesh, Østergaard, Lars, Klastrup, Vibeke, Khan, Maryam, Schleimann, Mariane H., Olesen, Rikke, Støvring, Henrik, Denton, Paul W., Kinloch, Natalie N., Copertino, Dennis C., Ward, Adam R., Alberto, Winiffer D.Conce, Nielsen, Silke D., Puertas, Maria C., Ramos, Victor, Reeves, Jacqueline D., Petropoulos, Christos J., Martinez-Picado, Javier, Brumme, Zabrina L., Jones, R. Brad, Fox, Julie, Tolstrup, Martin, Nussenzweig, Michel C., Caskey, Marina, Fidler, Sarah, Søgaard, Ole S.

المصدر: Gunst , J D , Pahus , M H , Rosás-Umbert , M , Lu , I N , Benfield , T , Nielsen , H , Johansen , I S , Mohey , R , Østergaard , L , Klastrup , V , Khan , M , Schleimann , M H , Olesen , R , Støvring , H , Denton , P W , Kinloch , N N , Copertino , D C , Ward , A R , Alberto , W D C , Nielsen , S D , Puertas , M C , Ramos , ....

مصطلحات موضوعية: Anti-Retroviral Agents/therapeutic use, CD4-Positive T-Lymphocytes, Depsipeptides/therapeutic use, Female, HIV Infections, HIV-1, Humans, Male, Proviruses, Viral Load

الاتاحة: https://pure.au.dk/portal/en/publications/534152d2-cd5f-402e-9579-3bfb00daf896
https://doi.org/10.1038/s41591-022-02023-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189540/pdf/nihms-1880982.pdf

المؤلفون: Camus, V., Thieblemont, C., Gaulard, P., Cheminant, M., Casasnovas, R.O., Ysebaert, L., Damaj, G.L., Guidez, S., Pica, G.M., Kim, W.S., Lim, S.T., Andre, M., Gutiérrez, N., Penarrubia, M.J., Staber, P.B., Trotman, J., Hüttmann, A., Stefoni, V., Tucci, A., Fogarty, P., Farhat, H., Abraham, J., Abarah, W., Belmecheri, F., Ribrag, V., Delfau-Larue, M.H., Cottereau, A.S., Itti, E., Li, J., Delarue, R., de Leval, L., Morschhauser, F., Bachy, E.

المصدر: Journal of clinical oncology, vol. 42, no. 14, pp. 1612-1618

مصطلحات موضوعية: Humans, Lymphoma, T-Cell, Peripheral/drug therapy, Peripheral/mortality, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cyclophosphamide/administration & dosage, Cyclophosphamide/therapeutic use, Doxorubicin/administration & dosage, Doxorubicin/therapeutic use, Vincristine/administration & dosage, Vincristine/therapeutic use, Prednisone/administration & dosage, Prednisone/therapeutic use, Depsipeptides/administration & dosage, Depsipeptides/therapeutic use, Middle Aged, Male, Female, Aged, Adult, Progression-Free Survival

Relation: info:eu-repo/semantics/altIdentifier/pmid/38364196; info:eu-repo/semantics/altIdentifier/eissn/1527-7755; https://serval.unil.ch/notice/serval:BIB_49FD96080F02

الاتاحة: https://serval.unil.ch/notice/serval:BIB_49FD96080F02
https://doi.org/10.1200/JCO.23.01687

المؤلفون: Dupuis, J., Bachy, E., Morschhauser, F., Cartron, G., Fukuhara, N., Daguindau, N., Casasnovas, R.O., Snauwaert, S., Gressin, R., Fox, C.P., d'Amore, F.A., Staber, P.B., Tournilhac, O., Bouabdallah, K., Thieblemont, C., André, M., Rai, S., Ennishi, D., Gkasiamis, A., Nishio, M., Fornecker, L.M., Delfau-Larue, M.H., Sako, N., Mule, S., de Leval, L., Gaulard, P., Tsukasaki, K., Lemonnier, F.

المصدر: The Lancet. Haematology, vol. 11, no. 6, pp. e406-e414

مصطلحات موضوعية: Humans, Male, Female, Aged, Middle Aged, Azacitidine/therapeutic use, Azacitidine/adverse effects, Azacitidine/administration & dosage, Administration, Oral, Bendamustine Hydrochloride/therapeutic use, Bendamustine Hydrochloride/administration & dosage, Bendamustine Hydrochloride/adverse effects, Gemcitabine, Lymphoma, Follicular/drug therapy, Follicular/mortality, Deoxycytidine/analogs & derivatives, Deoxycytidine/therapeutic use, Deoxycytidine/administration & dosage, Deoxycytidine/adverse effects, Depsipeptides/therapeutic use, Depsipeptides/adverse effects, Depsipeptides/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antimetabolites, Antineoplastic/therapeutic use, Antineoplastic/adverse effects, Antineoplastic/administration & dosage

Relation: info:eu-repo/semantics/altIdentifier/pmid/38796193; info:eu-repo/semantics/altIdentifier/eissn/2352-3026; https://serval.unil.ch/notice/serval:BIB_90411DAD960E

الاتاحة: https://serval.unil.ch/notice/serval:BIB_90411DAD960E
https://doi.org/10.1016/S2352-3026(24)00102-9

المؤلفون: Bachy, E., Camus, V., Thieblemont, C., Sibon, D., Casasnovas, R.O., Ysebaert, L., Damaj, G., Guidez, S., Pica, G.M., Kim, W.S., Lim, S.T., André, M., García-Sancho, A.M., Penarrubia, M.J., Staber, P.B., Trotman, J., Hüttmann, A., Stefoni, V., Re, A., Gaulard, P., Delfau-Larue, M.H., de Leval, L., Meignan, M., Li, J., Morschhauser, F., Delarue, R.

المصدر: Journal of clinical oncology, vol. 40, no. 3, pp. 242-251

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Asia, Australia, Cyclophosphamide/adverse effects, Cyclophosphamide/therapeutic use, Depsipeptides/adverse effects, Depsipeptides/therapeutic use, Disease Progression, Doxorubicin/adverse effects, Doxorubicin/therapeutic use, Europe, Female, Histone Deacetylase Inhibitors/adverse effects, Histone Deacetylase Inhibitors/therapeutic use, Humans, Lymphoma, T-Cell, Peripheral/drug therapy, Peripheral/mortality, Peripheral/pathology, Male, Middle Aged, Prednisone/adverse effects, Prednisone/therapeutic use, Progression-Free Survival, Time Factors

Relation: info:eu-repo/semantics/altIdentifier/pmid/34843406; info:eu-repo/semantics/altIdentifier/eissn/1527-7755; https://serval.unil.ch/notice/serval:BIB_176EB32E5BC5

الاتاحة: https://serval.unil.ch/notice/serval:BIB_176EB32E5BC5
https://doi.org/10.1200/JCO.21.01815

المساهمون: College of Medicine, Dept. of Internal Medicine, S. J. Kim, J. H. Kim, C. S. Ki, Y. H. Ko, J. S. Kim, W. S. Kim, Kim, Jin Seok

مصطلحات موضوعية: Antibiotics, Antineoplastic/adverse effects, Antineoplastic/therapeutic use, Cell Line, Tumor, DNA, Viral/blood, Depsipeptides/adverse effects, Depsipeptides/therapeutic use, Epstein-Barr Virus Infections/pathology, Epstein-Barr Virus Infections/virology, Female, Herpesvirus 4, Human/drug effects, Histone Deacetylase Inhibitors/adverse effects, Histone Deacetylase Inhibitors/therapeutic use, Humans, Lymphoma, Extranodal NK-T-Cell/drug therapy, Male, Middle Aged, Pilot Projects, Prospective Studies, Virus Activation/drug effects, EBV reactivation, extranodal NK/T-cell lymphoma, romidepsin

Relation: ANNALS OF ONCOLOGY; J00171; OAK-2016-07703; https://ir.ymlib.yonsei.ac.kr/handle/22282913/152758; T201605293; ANNALS OF ONCOLOGY, Vol.27(3) : 508-513, 2016

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/152758
https://doi.org/10.1093/annonc/mdv596
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdv596

المؤلفون: Tapia, G., Højen, J.F., Ökvist, M., Olesen, R., Leth, S., Nissen, S.K., VanBelzen, D.J., O'Doherty, U., Mørk, A., Krogsgaard, K., Søgaard, O.S., Østergaard, L., Tolstrup, M., Pantaleo, G., Sommerfelt, M.A.

المصدر: The Journal of infection, vol. 75, no. 6, pp. 555-571

مصطلحات موضوعية: AIDS Vaccines/immunology, AIDS Vaccines/therapeutic use, Adult, Anti-Retroviral Agents/therapeutic use, CD8-Positive T-Lymphocytes/immunology, Cytokines/immunology, Denmark, Depsipeptides/therapeutic use, Drug Therapy, Combination, Female, HIV Seropositivity/drug therapy, HIV Seropositivity/therapy, HIV-1, Humans, Immunity, Cellular, Immunotherapy, Male, Viral Load/immunology, Virus Latency/immunology, HDACi, HIV, Latency reversal, Romidepsin, Therapeutic vaccine, Vacc-4x

Relation: info:eu-repo/semantics/altIdentifier/pmid/28917661; info:eu-repo/semantics/altIdentifier/eissn/1532-2742; https://serval.unil.ch/notice/serval:BIB_8AF88D92E5B7

الاتاحة: https://serval.unil.ch/notice/serval:BIB_8AF88D92E5B7
https://doi.org/10.1016/j.jinf.2017.09.004